1Y Close · As of Aug 26, 2026
SAMIK PHARM operates in the Pharmaceuticals sector.
Legal name: SAMIK PHARM. CO.,LTD.
In fiscal year 2025, SAMIK PHARM (014950) reported revenue of 60.0 billion KRW, up 7.5% from 55.9 billion KRW a year earlier.
Operating profit was 3.3 billion KRW and net income was -755 million KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 50.3 billion KRW, with a P/B of 0.73.
These figures can be verified in the DART filing (receipt no. 20260320000589).
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |